1. DiMasi JA, Grabowski HG, Hansen RA (2016) Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ 47:20–33
2. Sorger PK, Allerheiligen SRB, Abernethy DR, Altman RB, Brouwer KLR, Califano A, D’Argenio DZ, Iyengar R, Jusko WJ, Lalonde R, Lauffenburger DA, Shoichet B, Stevens JL, Subramaniam S, Van der Graaf P, Vicini P, Ward R (2011) Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms. An NIH White Paper by the QSP Workshop Group. National Institutes of Health website. https://www.nigms.nih.gov/training/documents/systemspharmawpsorger2011.pdf . Accessed 4 Jan 2018
3. Obituary: Colin Day (2012) Santa Barbara Independent website. http://www.independent.com/obits/2012/feb/21/colin-day/ . Accessed 4 June 2017
4. Goldie JH, Coldman AJ (1986) Application of theoretical models to chemotherapy protocol design. Cancer Treat Rep 70(1):127–31
5. Day RS (1986) Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy. Cancer Res 46(8):3876–3885